Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis

• Published in: Endoscopy Vol. 55; no. 6; p. 508
• Main Authors: Wadhwa, Vaibhav, Gonzalez, Adalberto, Azar, Francisco, Singh, Harjinder, Gupta, Kapil, Liang, Hong, Schneider, Alison, Ponsky, Jeffery, Erim, Tolga, Rodriguez, John, Castro, Fernando J
• Format: Journal Article
• Language: English
• Published: Germany 01.06.2023
• Subjects: Botulinum Toxins - therapeutic use; Gastric Emptying; Gastroparesis - drug therapy; Gastroparesis - etiology; Gastroparesis - surgery; Humans; Pyloromyotomy - adverse effects; Retrospective Studies; Treatment Outcome
• ISSN: 1438-8812
• DOI: 10.1055/a-1986-4292

BACKGROUND : Patients with gastroparesis who have undergone prior intrapyloric botulinum toxin injection (BTI) may seek an opinion regarding peroral pyloromyotomy (POP). There are only two small reports assessing the role of BTI as a predictor for successful treatment with POP. We performed a retrospective cohort study to assess whether symptomatic improvement after BTI predicts a response to POP. We included 119 patients who had undergone both BTI and POP at Cleveland Clinic Ohio or Cleveland Clinic Florida from January 2016 to September 2019. 65.5 % of patients had symptomatic improvement after BTI. Gastroparesis Cardinal Symptom Index (GCSI) scores were available for 74 patients, with 64 % achieving a response to POP, defined as a decrease in mean GCSI ≥ 1. In multivariable analysis, response to BTI (odds ratio [OR] 7.7 [95 %CI 2.2-26.1]) and higher pre-POP GCSI score (OR 2.3 [95 %CI 1.2-4.6]) were independent predictors of response to POP. Clinical improvement after BTI is a predictor of response to POP in patients with gastroparesis. This information may aid in improving patient selection for POP.